Second-line nivolumab/ipilimumab boost improves ORR in metastatic urothelial carcinoma Presented ByProf. Marc-Oliver Grimm, University Hospital Jena, Germany TrialPhase 2, TITAN-TCC ConferenceASCO GU 2022 TypePeer-reviewed article 8 April 2022 11:17